Liabilities, Current in USD of BIO-TECHNE Corp from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
BIO-TECHNE Corp quarterly Liabilities, Current history and change rate from Q2 2010 to Q3 2025.
  • BIO-TECHNE Corp Liabilities, Current for the quarter ending 30 Sep 2025 was $145M, a 1.7% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $145M +$2.42M +1.7% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $176M +$16.5M +10.3% 30 Jun 2025 10-Q 05 Nov 2025
Q1 2025 $169M +$19.4M +12.9% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $161M +$26M +19.2% 31 Dec 2024 10-Q 06 Feb 2025
Q3 2024 $142M +$14.4M +11.3% 30 Sep 2024 10-Q 05 Nov 2024
Q2 2024 $159M +$30.9M +24% 30 Jun 2024 10-K 22 Aug 2025
Q1 2024 $150M +$8.66M +6.13% 31 Mar 2024 10-Q 06 May 2024
Q4 2023 $135M +$6.84M +5.32% 31 Dec 2023 10-Q 07 Feb 2024
Q3 2023 $128M -$9.88M -7.18% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $129M -$47.5M -27% 30 Jun 2023 10-K 22 Aug 2024
Q1 2023 $141M -$25.7M -15.4% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 $128M -$26.4M -17.1% 31 Dec 2022 10-Q 07 Feb 2023
Q3 2022 $138M +$3.64M +2.71% 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $176M +$23.7M +15.6% 30 Jun 2022 10-K 23 Aug 2023
Q1 2022 $167M +$29.2M +21.2% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $155M +$37.2M +31.7% 31 Dec 2021 10-Q 07 Feb 2022
Q3 2021 $134M +$28.6M +27.1% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 $152M +$45.6M +42.8% 30 Jun 2021 10-K 24 Aug 2022
Q1 2021 $138M +$32.7M +31.1% 31 Mar 2021 10-Q 07 May 2021
Q4 2020 $118M +$12.6M +12% 31 Dec 2020 10-Q 08 Feb 2021
Q3 2020 $105M +$17.2M +19.4% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $107M +$4.68M +4.59% 30 Jun 2020 10-K 25 Aug 2021
Q1 2020 $105M +$6.94M +7.08% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $105M +$17.5M +20% 31 Dec 2019 10-Q 06 Feb 2020
Q3 2019 $88.3M +$4.83M +5.78% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $102M +$22.5M +28.3% 30 Jun 2019 10-K 26 Aug 2020
Q1 2019 $98M +$27.2M +38.3% 31 Mar 2019 10-Q 07 May 2019
Q4 2018 $87.4M -$24.2M -21.7% 31 Dec 2018 10-Q 07 Feb 2019
Q3 2018 $83.4M -$23.6M -22% 30 Sep 2018 10-Q 07 Nov 2018
Q2 2018 $79.5M -$56M -41.3% 30 Jun 2018 10-K/A 06 Nov 2019
Q1 2018 $70.9M -$71.3M -50.1% 31 Mar 2018 10-Q 09 May 2018
Q4 2017 $112M -$8.65M -7.19% 31 Dec 2017 10-Q 08 Feb 2018
Q3 2017 $107M +$15K +0.01% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $136M +$81.4M +150% 30 Jun 2017 10-K 27 Aug 2018
Q1 2017 $142M +$95.6M +205% 31 Mar 2017 10-Q 10 May 2017
Q4 2016 $120M +$84.5M +236% 31 Dec 2016 10-Q 09 Feb 2017
Q3 2016 $107M +$62M +138% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $54.1M +$14.4M +36.2% 30 Jun 2016 10-K 07 Sep 2017
Q1 2016 $46.6M +$8.1M +21% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $35.8M -$8.45M -19.1% 31 Dec 2015 10-Q 09 Feb 2016
Q3 2015 $45M +$4.42M +10.9% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 $39.8M +$13.4M +50.7% 30 Jun 2015 10-K 29 Aug 2016
Q1 2015 $38.5M +$14.1M +58.1% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $44.3M +$22.2M +100% 31 Dec 2014 10-Q 09 Feb 2015
Q3 2014 $40.6M +$20.3M +100% 30 Sep 2014 10-Q 10 Nov 2014
Q2 2014 $26.4M -$5.69M -17.7% 30 Jun 2014 10-K 31 Aug 2015
Q1 2014 $24.4M -$8.12M -25% 31 Mar 2014 10-Q 12 May 2014
Q4 2013 $22.1M +$841K +3.95% 31 Dec 2013 10-Q 04 Feb 2014
Q3 2013 $20.3M -$2.63M -11.5% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $32.1M -$3.67M -10.3% 30 Jun 2013 10-K 29 Aug 2014
Q1 2013 $32.5M +$1.76M +5.73% 31 Mar 2013 10-Q 10 May 2013
Q4 2012 $21.3M +$7.15M +50.6% 31 Dec 2012 10-Q 11 Feb 2013
Q3 2012 $22.9M -$3.34M -12.7% 30 Sep 2012 10-Q 09 Nov 2012
Q2 2012 $35.8M +$17.6M +96.6% 30 Jun 2012 10-K 29 Aug 2013
Q1 2012 $30.7M +$14.2M +85.7% 31 Mar 2012 10-Q 10 May 2012
Q4 2011 $14.1M +$451K +3.3% 31 Dec 2011 10-Q 07 Feb 2012
Q3 2011 $26.2M +$10.2M +63.4% 30 Sep 2011 10-Q 09 Nov 2011
Q2 2011 $18.2M +$1.16M +6.84% 30 Jun 2011 10-K 29 Aug 2012
Q1 2011 $16.5M 31 Mar 2011 10-Q 10 May 2011
Q4 2010 $13.7M 31 Dec 2010 10-Q 09 Feb 2011
Q3 2010 $16.1M 30 Sep 2010 10-Q 09 Nov 2010
Q2 2010 $17M 30 Jun 2010 10-K 29 Aug 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.